Published in Arch Dermatol on March 01, 1991
Leg ulcers. J Am Acad Dermatol (1991) 2.74
Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol (2001) 2.33
Treatment of tattoos by Q-switched ruby laser. A dose-response study. Arch Dermatol (1990) 2.01
Selective photothermolysis of cutaneous pigmentation by Q-switched Nd: YAG laser pulses at 1064, 532, and 355 nm. J Invest Dermatol (1989) 1.60
Laser treatment of pigmented lesions--2000: how far have we gone? Arch Dermatol (2000) 1.54
Brief report: graft-versus-host disease associated with transfusion of blood from unrelated HLA-homozygous donors. N Engl J Med (1993) 1.46
Transfusion-associated graft-vs-host disease in patients with malignancies. Report of two cases and review of the literature. Arch Dermatol (1990) 1.42
Facial skin rejuvenation: laser resurfacing or chemical peel: choose your weapon. Dermatol Surg (2001) 1.39
Keloids and hypertrophic scars: review and treatment strategies. Semin Cutan Med Surg (1999) 1.37
Necrobiosis lipoidica. J Am Acad Dermatol (1991) 1.16
The role of lasers and light sources in the treatment of leg veins. Dermatol Surg (1999) 1.11
Chronic localized herpes zoster in the acquired immunodeficiency syndrome. Arch Dermatol (1990) 1.10
Prevalence of skin disease in a cohort of shelter-based homeless men. J Am Acad Dermatol (1999) 1.10
Treatment of minocycline-induced hyperpigmentation with the Q-switched ruby laser. Arch Dermatol (1996) 0.99
Accessibility and reliability of cutaneous laser surgery information on the World Wide Web. J Am Acad Dermatol (2000) 0.98
Disseminated superficial actinic porokeratosis. Coexistence with other porokeratotic variants. Arch Dermatol (1986) 0.93
Release of prostaglandin D2 and histamine in a case of localized heat urticaria, and effect of treatments. Br J Dermatol (1986) 0.92
Serum albumin. Differences in assay specificity. Nutr Clin Pract (1989) 0.91
Birt-Hogg-Dube syndrome: treatment of cutaneous manifestations with laser skin resurfacing. Arch Dermatol (2001) 0.90
Vancomycin-induced linear IgA bullous dermatosis. Arch Dermatol (1988) 0.89
A clinical and histologic prospective controlled comparative study of the picosecond titanium:sapphire (795 nm) laser versus the Q-switched alexandrite (752 nm) laser for removing tattoo pigment. J Am Acad Dermatol (1999) 0.89
LH-RH testing in men with Down's syndrome. Acta Endocrinol (Copenh) (1978) 0.89
Exercise-induced anaphylaxis (EIA). Clin Rev Allergy Immunol (1999) 0.88
Recent advances in dermatology. N Engl J Med (1992) 0.88
Basic laser principles. Dermatol Clin (1997) 0.88
Q-switched ruby laser irradiation of normal human skin. Histologic and ultrastructural findings. Arch Dermatol (1991) 0.87
Melanosomes are a primary target of Q-switched ruby laser irradiation in guinea pig skin. J Invest Dermatol (1987) 0.86
On beauty: evolution, psychosocial considerations, and surgical enhancement. Arch Dermatol (2001) 0.86
Cutaneous polyarteritis nodosa associated with hepatitis B surface antigen. J Am Acad Dermatol (1986) 0.86
Fractional Laser treatment for pigmentation and texture improvement. Skin Therapy Lett (2006) 0.85
Laser therapy versus cryotherapy of lentigines: a comparative trial. J Am Acad Dermatol (1994) 0.85
Sebaceous adenoma in a patient with acquired immunodeficiency syndrome. Arch Dermatol (1988) 0.82
Interaction between cyclosporin and rifampicin. Lancet (1984) 0.81
The use of lasers for decorative tattoo removal. Skin Therapy Lett (2006) 0.81
Lichenoid dermatoses and related disorders. II. Lichen nitidus, lichen sclerosus et atrophicus, benign lichenoid keratoses, lichen aureus, pityriasis lichenoides, and keratosis lichenoides chronica. J Am Acad Dermatol (1990) 0.81
Pemphigus foliaceus induced by psoralen-UV-A. Arch Dermatol (1998) 0.81
Laser skin resurfacing. Arch Dermatol (1996) 0.81
Pancytopenia induced by the interaction between methotrexate and trimethoprim-sulfamethoxazole. J Am Acad Dermatol (1987) 0.81
Evaluation of a silicone occlusive dressing after laser skin resurfacing. Arch Dermatol (2001) 0.81
Autonomic neurodermatology (Part II): Disorders of sweating and flushing. Semin Neurol (1992) 0.80
Treatment of acne scarring. Skin Therapy Lett (2006) 0.80
Visible action spectrum for melanin-specific selective photothermolysis. Lasers Surg Med (1989) 0.79
A clinical overview of hair removal using lasers and light sources. Dermatol Clin (1999) 0.79
Atypical angiomatosis in polyarteritis nodosa. Br J Dermatol (1986) 0.78
Recent onset of gingival enlargement. Arch Dermatol (1986) 0.78
Mast-cell phenotype in indolent forms of mastocytosis. Ultrastructural features, fluorescence detection of avidin binding, and immunofluorescent determination of chymase, tryptase, and carboxypeptidase. Am J Pathol (1992) 0.78
The use of lasers in the pediatric population. Skin Therapy Lett (2005) 0.77
Characterization of cellular dermal infiltrates in human cutaneous mastocytosis. Lab Invest (1990) 0.77
Laser treatment of tattoos: a prospective, paired, comparison study of the Q-switched Nd:YAG (1064 nm), frequency-doubled Q-switched Nd:YAG (532 nm), and Q-switched ruby lasers. J Am Acad Dermatol (1997) 0.77
Nonablative laser and light therapy: an approach to patient and device selection. Skin Therapy Lett (2003) 0.77
Lasers in dermatology--1993. Arch Dermatol (1993) 0.76
Pulsed dye laser-resistant port-wine stains. Arch Dermatol (1996) 0.76
Kaposi's sarcoma and Mycobacterium avium-intracellulare with cellulitis in patient with acquired immunodeficiency syndrome. J Am Acad Dermatol (1989) 0.76
Acute hemolysis and renal failure with rifampicin-dependent antibodies after discontinuous administration. Transfusion (1985) 0.76
A reaction to a red lip cosmetic tattoo. J Am Acad Dermatol (1998) 0.75
Spontaneous bullae over laser resurfaced skin. J Am Acad Dermatol (2000) 0.75
[Lasers and aesthetic dermatology]. Hautarzt (2003) 0.75
Immunohistological comparison of granulated cell proteins in induced immediate urticarial dermographism and delayed pressure urticaria lesions. Br J Dermatol (1995) 0.75
Treatment of photoaging with topical aminolevulinic acid and light. Skin Therapy Lett (2005) 0.75
Aesthetic surgery: coming of age. Lancet (2000) 0.75
Advances in cutaneous aesthetic surgery. JAMA (1998) 0.75
Stevens-Johnson-type reaction with vancomycin treatment. Ann Pharmacother (1992) 0.75
Lasers. J Am Acad Dermatol (1995) 0.75
Law enforcement and drug abuse. Clin Proc Child Hosp Dist Columbia (1968) 0.75
Psoralens. New formulation! Better formulation? Arch Dermatol (1986) 0.75
Recent therapeutic advances in dermatology. JAMA (2000) 0.75
Herpes simplex. Semin Neurol (1992) 0.75
Ecthymalike lesions on the leg of an immunocompromised patient. Primary cutaneous mucormycosis. Arch Dermatol (1995) 0.75
Cutaneous manifestations of human immunodeficiency virus infection. Semin Neurol (1992) 0.75
A child with hair loss. Pili torti, apparently unassociated with other abnormalities. Arch Dermatol (1987) 0.75
Aspirin treatment of patients with aspirin intolerance, asthma, and nasal polyps. Allergy Asthma Proc (2002) 0.75
Severe hemorrhage from a 4 mm punch biopsy site in a hemophilia patient with acquired immunodeficiency syndrome. J Am Acad Dermatol (1989) 0.75
Eczematous plaques in a patient with liver failure. Fat-soluble vitamin K hypersensitivity. Arch Dermatol (1992) 0.75
Use of cutaneous lasers and light sources: appropriate training and delegation. Skin Therapy Lett (2007) 0.75
Dermatology. JAMA (1989) 0.75
Keratinocyte protein expression in rapidly regenerating epidermis following laser-induced thermal injury. Lasers Surg Med (1989) 0.75
Dermatology. JAMA (1990) 0.75
Images in clinical medicine. Basal-cell carcinoma. N Engl J Med (1993) 0.75
Are all 585 nm pulsed dye lasers equivalent? A prospective, comparative, photometric, and histologic study. J Am Acad Dermatol (1996) 0.75
Autonomic neurodermatology (Part I): Erythromelalgia, reflex sympathetic dystrophy, and livedo reticularis. Semin Neurol (1992) 0.75
Linear porokeratosis of Mibelli and DSAP. Clin Exp Dermatol (1986) 0.75
Comparison of the 595 nm long-pulse (1.5 msec) and ultralong-pulse (4 msec) lasers in the treatment of leg veins. Dermatol Surg (1999) 0.75
Current concepts of urticaria and angioedema. Allergy Proc (1989) 0.75
Psoriasiform papules in the acquired immunodeficiency syndrome. Disseminated histoplasmosis in AIDS. Arch Dermatol (1991) 0.75
CO2 laser resurfacing: why all the fuss? Plast Reconstr Surg (1996) 0.75
Lichen planus localized to the nails. J Cutan Med Surg (1998) 0.75
Lichenoid dermatoses and related disorders. I. Lichen planus and lichenoid drug-induced eruptions. J Am Acad Dermatol (1990) 0.75
Malignant pyoderma: a manifestation of Wegener's granulomatosis? J Am Acad Dermatol (1986) 0.75
Allergic skin disorders and mastocytosis. JAMA (1992) 0.75
Recurrent exacerbation of acne by granulocyte colony-stimulating factor administration. J Am Acad Dermatol (1996) 0.75
Lasers for vascular lesions. Dermatol Nurs (1999) 0.75
Successful treatment of eruptive pyoderma gangrenosum with intravenous vancomycin and mezlocillin. Br J Dermatol (1990) 0.75